PRL phosphatase targeting chimeric mAbs (Agency For Science Technology & Research)

N/A

Report date: 2025/03/20 14:39:42

Base Information

Drug NamePRL phosphatase targeting chimeric mAbs (Agency For Science Technology & Research)
Drug Alias Nameprotein tyrosine phosphatase inhibitors (Agency For Science Technology & Research)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionProtein tyrosine phosphatase inhibitors
TargetsProtein tyrosine phosphatase
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Agency for Science Technology and Research
China Registration ClassN/A

Develop Information

Active CompaniesAccelerate Technologies Pte LtdThe Agency for Science Technology and Research
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A